| human | Q5 |
| P496 | ORCID iD | 0000-0002-5037-0611 |
| P1153 | Scopus author ID | 7007045784 |
| P69 | educated at | Sapienza University of Rome | Q209344 |
| P734 | family name | De Santis | Q60182668 |
| De Santis | Q60182668 | ||
| De Santis | Q60182668 | ||
| P735 | given name | Rita | Q1094218 |
| Rita | Q1094218 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q37598729 | Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals |
| Q89699307 | Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy |
| Q39683499 | Anti-proliferative effect of a triazole derivative (ST1959) on LNCaP human prostate cancer cells through down-regulation of cyclin and androgen receptor expression. |
| Q57139824 | Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation |
| Q80350297 | Antibody-based cancer therapies: back to "polyclonals"? |
| Q38967404 | AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies. |
| Q47898476 | AvidinOX™ for tissue targeted delivery of biotinylated cells. |
| Q30384834 | Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties. |
| Q47371861 | Characterization of therapeutic protein AvidinOX by an integrated analytical approach. |
| Q28478646 | Chemical linkage to injected tissues is a distinctive property of oxidized avidin |
| Q41184671 | Clavin, a type-1 ribosome-inactivating protein from Aspergillus clavatus IFO 8605. cDNA isolation, heterologous expression, biochemical and biological characterization of the recombinant protein. |
| Q40390563 | Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma |
| Q52570637 | Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy. |
| Q33319869 | Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88. |
| Q51932469 | Dissecting drug and vehicle metabolic effects in rats by a metabonomic approach. |
| Q41182691 | Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis. |
| Q34298803 | Efficacy of PTX3 and posaconazole combination in a rat model of invasive pulmonary aspergillosis |
| Q46127184 | Efficacy of a nanocochleate-encapsulated 3,5-diaryl-s-triazole derivative in a murine model of graft-versus-host disease. |
| Q38955008 | Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab |
| Q83931393 | Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT) |
| Q52668200 | Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy. |
| Q74630707 | Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15 |
| Q73049734 | Expression and characterization of a mouse/human chimeric antibody specific for EGF receptor |
| Q91651258 | Growth inhibition of human ovarian carcinoma by a novel AvidinOX-anchored biotinylated camptothecin derivative |
| Q90897825 | Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo |
| Q112707921 | Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy |
| Q33231683 | Identification and refinement of a peptide affinity ligand with unique specificity for a monoclonal anti-tenascin-C antibody by screening of a phage display library. |
| Q36729566 | Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer. |
| Q34689002 | Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer |
| Q43275529 | Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin. |
| Q40293661 | Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody. |
| Q34285473 | Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody |
| Q34159058 | Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response |
| Q33622702 | OXavidin for tissue targeting biotinylated therapeutics. |
| Q56942190 | PTX3 Binds MD-2 and Promotes TRIF-Dependent Immune Protection in Aspergillosis |
| Q56942879 | Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation |
| Q77571558 | Pharmacokinetic and immunogenic behavior of three recombinant human GM-CSF-EPO hybrid proteins in cynomolgus monkeys |
| Q51039778 | Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. |
| Q80428452 | Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound |
| Q35742395 | Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor. |
| Q80681507 | Pretargeted antibody-guided radioimmunotherapy in a child affected by resistant anaplastic large cell lymphoma |
| Q40932752 | Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice. |
| Q36074100 | Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm |
| Q61208511 | Role of Cross-Linking Agents in Determining the Biochemical and Pharmacokinetic Properties of Mgr6−Clavin Immunotoxins |
| Q25256754 | Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein |
| Q35001176 | Simultaneous display of two large proteins on the head and tail of bacteriophage lambda |
| Q46788898 | Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization |
| Q33257880 | Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. |
| Q40879546 | The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesis. |
| Q42477444 | Therapeutic Use of Avidin Is Not Hampered by Antiavidin Antibodies in Humans |
| Q59157110 | Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance |
| Q35934478 | Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance. |
| Q33303060 | Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells. |
Search more.